Katarzyna Bialkowska
Szczecin, ZP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.
Journal: Journal of the National Cancer Institute
Published: February 25, 2026
The contribution of rare germline variants to the immune landscape of breast cancer.
Journal: Genome medicine
Published: April 28, 2025
BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients.
Journal: Hereditary cancer in clinical practice
Published: April 17, 2025
Insights into genetic modifiers of breast cancer risk in carriers of BRCA1 and BRCA2 pathogenic variants.
Journal: Hereditary cancer in clinical practice
Published: February 14, 2025
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.
Journal: iScience
Published: January 31, 2025
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.
Journal: Breast cancer research : BCR
Published: August 12, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Journal: medRxiv : the preprint server for health sciences
Published: March 18, 2024
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2024
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
Journal: NPJ breast cancer
Published: November 13, 2022
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Journal: Hereditary cancer in clinical practice
Published: December 22, 2021
Last Updated: 09/26/2026